#67 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
This article matters for clinicians and their patients because it highlights the dual role of cannabis components – cannabinoids (THC, CBD, CBG) and terpenes. While cannabinoids are linked to the plant’s primary effects, terpenes may influence these effects by modifying the way cannabinoids interact with the endocannabinoid system. Understanding this interplay can aid clinicians in tailoring medical cannabis treatments for optimal patient outcomes.
Terpenes, distinct from cannabinoids like THC, CBD, and CBG, are aromatic compounds found in cannabis that may contribute to its therapeutic benefits by modulating the effects of cannabinoids within the endocannabinoid system. Understanding both terpenes and cannabinoids is crucial for optimizing medical cannabis treatment strategies, as they can influence the plant’s overall efficacy and potential side effects for patients.
“As a seasoned family physician specializing in cannabis medicine, I find it noteworthy that both cannabinoids and terpenes play integral roles in the medical cannabis discourse. While cannabinoids like THC, CBD, and CBG primarily interact with the endocannabinoid system to elicit the plant’s primary effects, terpenes contribute subtly yet significantly to the overall therapeutic profile, modulating these effects and potentially enhancing their efficacy.” – Dr. Benjamin Caplan, MD
🌿 In the medical cannabis discourse, it’s essential to recognize that both cannabinoids (like THC, CBD, and CBG) and terpenes play significant roles. While cannabinoids primarily interact with the endocannabinoid system, influencing the plant’s main effects, terpenes contribute to the overall aroma, flavor, and potentially, therapeutic properties of cannabis strains. However, the complex interplay between these compounds, their individual and combined effects, and potential confounders such as strain variability, dosage, and route of administration, necessitate a nuanced approach in clinical practice. Practically, healthcare providers should consider both cannabinoid and terpene profiles when counseling patients about medical cannabis use, aiming to optimize therapeutic benefits while minimizing potential adverse effects.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
